Product Information
LANSOPRAZOLE DR 30 MG ODT is a generic product labeled by Aurobindo Pharma Limited, priced at $2.2103 per EA under NDC 65862089678. Its NADAC has been published 141 times since Dec 13, 2023.
FDA first approved this application on Mar 28, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Lansoprazole market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
30 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
65862089678
Classification
Generic
Dosage Form
TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
LANSOPRAZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA207167FDA Approved
3/28/2023
TE Code
AB
On Market Since
3/28/2023
Pharmacological Classes
Price Statistics
The NADAC for LANSOPRAZOLE DR 30 MG ODT has been published 141 times since Dec 13, 2023, and over the history we have for it it has declined 52.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.2103 per EA |
|---|---|
| All-time high | $4.6410 (Dec 13, 2023) |
| All-time low | $1.8384 (Apr 22, 2026) |
| 52-week high | $2.8016 |
| 52-week low | $1.8384 |
| Median price | $2.4560 |
| Average price | $2.5884 |
| Largest weekly change | -27.1% (Jan 17, 2024) |
| Weeks tracked | 141 |
| Tracking since | Dec 13, 2023 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of LANSOPRAZOLE DR 30 MG ODT?
The current National Average Drug Acquisition Cost (NADAC) for LANSOPRAZOLE DR 30 MG ODT, manufactured by Aurobindo Pharma Limited, is $2.2103 per EA (NDC 65862089678), effective Aug 19, 2026.
How has the price of LANSOPRAZOLE DR 30 MG ODT changed over time?
Over the history we have for it, the NADAC for LANSOPRAZOLE DR 30 MG ODT has declined 52.4%. It has been tracked across 141 weekly CMS publications since Dec 13, 2023.
What are the highest and lowest recorded NADAC prices for LANSOPRAZOLE DR 30 MG ODT?
Since Dec 13, 2023, the NADAC for LANSOPRAZOLE DR 30 MG ODT has ranged from a low of $1.8384 (Apr 22, 2026) to a high of $4.6410 (Dec 13, 2023), with a median of $2.4560 per EA.
Are there cheaper alternatives to LANSOPRAZOLE DR 30 MG ODT?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as LANSOPRAZOLE DR 30 MG ODT in a comparable dosage form, but none are currently priced below it.
Who manufactures LANSOPRAZOLE DR 30 MG ODT?
LANSOPRAZOLE DR 30 MG ODT (NDC 65862089678) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.